Both in Pharmaceuticals
Geron vs Immix Biopharma
Over the past year GERN returned −10.2% and IMMX returned +137.5%; their daily moves had a correlation of 0.33.
GERN −10.2% IMMX +137.5%Growth of $1, one year, split-adjusted
| Metric | GERN | IMMX |
|---|---|---|
| Price | $1.15 | $8.05 |
| Market cap | $738.8M | $667.4M |
| Today | 0.00% | −0.12% |
| 1 month | −8.0% | −29.8% |
| 6 months | −23.8% | −6.4% |
| Year to date | −12.9% | +53.9% |
| 1 year | −7.3% | +123.0% |
| Revenue growth (YoY) | +17.2% | — |
| Gross margin | 83.9% | — |
| Net margin | −29.0% | — |
| P/E (TTM) | — | — |
| Price / sales | 3.6× | — |
| Net cash | $51.1M | $232.1M |
| Dividend yield | — | — |
| Volatility (60d) | 64.7% | 72.1% |
| Short % of float | 11.9% | 22.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).